The concentrations of IL-17 and TNF-α, two important proinflammatory cytokines, were prominently increased, whereas those of certain chemokines, such as RANTES, MIP-1α, MIP-1β, and MCP-1, were markedly decreased in MS-affected patients compared with those in healthy controls. This evidence concerns the gene IL17A and myeloid sarcoma.